Sign in

You're signed outSign in or to get full access.

DCVC Opportunity Fund II GP, LLC

CIK:0001668343
Venture Capital
$1B AUM
2 holdings
Palo Alto, CA, United States
Founded:2010
24 employees
Latest filing:Jun 30, 2025

DCVC (Data Collective) is a deep tech venture capital firm headquartered in Palo Alto, California. It was founded in 2010 and employs fewer than 25 people. The firm invests in innovative entrepreneurs and companies developing solutions to significant global challenges, particularly in sectors including artificial intelligence, climate technology, health, life sciences, and food production. DCVC supports ventures with dedicated climate and bio funds, focusing on impactful technologies and sustainable practices, and works with startups from seed to Series B stage.

Investment Strategy

DCVC invests in deep tech companies at the seed to Series B stages that leverage computational breakthroughs, biology, engineering, and advanced technologies to address high-stakes global challenges. Its investment approach emphasizes foundational science and engineering to create impactful solutions in health, sustainability, and climate. DCVC supports companies that combine scientific excellence with technological innovation, seeking outsized returns and meaningful contributions to society. Its funds, including dedicated climate and bio funds, back entrepreneurs with expertise in fields such as genetics, AI, industrial fermentation, and synthetic biology, aiming to bring breakthrough products to market and solve hard global problems.

Latest 13F Filing Activity

DCVC Opportunity Fund II GP, LLC filed their most recent 13F report on Jun 30, 2025 disclosing 2 equity positions with a total 13F market value of $115M. The fund increased holdings in Rocket Lab Corp., Recursion Pharmaceuticals, Inc.. DCVC Opportunity Fund II GP, LLC reduced exposure to Rocket Lab USA, Inc., Recursion Pharmaceuticals, Inc., Rocket Lab Corp..

Top Buys
R
RKLBRocket Lab Corp
+$95.3M
R
RXRXRecursion Pharmaceuticals, Inc.
-$908.8K
Top Sells
R
RKLBRocket Lab Corp
+$95.3M
R
RKLBRocket Lab USA, Inc.
-$60.6M
R
RXRXRecursion Pharmaceuticals, Inc.
-$908.8K

Top Holdings

R
RKLBRocket Lab Corp
+82.7%$95.3M
R
RXRXRecursion Pharmaceuticals, Inc.
+17.3%$20.0M

Equity Positions (2)

TickerSecurityWeightMarket ValueSharesAvg CostPriceChange (QoQ)
Rocket Lab Corp82.65%$95.3M2,663,139$35.77$35.77+$95.3M
Recursion Pharmaceuticals, Inc.17.35%$20.0M3,951,141$9.86$5.06-$908.8K

Industry Allocation

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+100.0%